PATENT IN JAPAN

DiaGenic has received “Decision to grant” for its Japanese patent Application No. 10-546756. The patent when granted will cover DiaGenic’s method of generating data for diagnosing diseases using blood samples and gene expression technology, wherein the said blood sample is obtained from a part of the body distant to the area of the disease. The patent cover several diseases, among these Alzheimer’s disease and cancer forms such as breast cancer. The method of probe selection is general and not limited to any one particular mode of selection.

MD PhD Erik Christensen, managing director of DiaGenic comments, “The new Japanese patent is an important milestone which strengthens our position in Asia. The company will now have a broad patent protection in Japan, which is the second largest economy in the world”.


Contact:
MD PhD Erik Christensen, Managing Director
Telephone: +47 95939918
e-mail: erik.christensen@diagenic.com